© Copyright Acquisition International 2025 - All Rights Reserved.

Article Image - OPKO Health Acquires EirGen Pharma
Posted 28th May 2015

OPKO Health Acquires EirGen Pharma

OPKO Health Acquires EirGen Pharma

Mouse Scroll AnimationScroll to keep reading

Let us help promote your business to a wider following.

OPKO Health Acquires EirGen Pharma

OPKO Health Acquires EirGen Pharma

View Biography
Image

Paul Heffernan, Legal Adviser OPKO Health

OPKO Health, Inc. is pleased to announce the acquisition of EirGen Pharma, Ltd., a growing, profitable and cash flow positive specialty pharmaceutical company focused on the development and commercial supply of high potency, high barrier to entry, pharmaceutical products for sale in the U.S., Canada, Japan, Australia, most European countries, and more than 40 others around the world.

EirGen, based in Waterford, Ireland, was founded by two former executives of IVAX Pharmaceuticals, Tom Brennan and Patsy Carney. The company, situated in a state of the art high containment research and development, and manufacturing facility, is approved by the FDA, EMEA (European Health Authorities) and the PMDA (Japanese Health Authorities). High potency drugs such as those used for cancer chemotherapy are typically unsuitable for manufacture in normal multi-product facilities due to cross contamination risks.

To date, EirGen and its commercial partners have filed 10 product applications with the FDA and 5 each in Europe and Japan. EirGen has a strong research and development portfolio of over 20 niche, high barrier to entry drugs and, with access to additional capital that OPKO will provide, together with the benefits of Irish government programs to encourage research and development in Ireland, EirGen will rapidly expand its drug portfolio.

“EirGen Pharma is one of the leading developers and suppliers of high potency niche pharmaceutical products in the world,” said Phillip Frost, M.D. OPKO’s Chairman and CEO. “As FineTech, OPKO’s Israeli active pharmaceutical ingredient manufacturing subsidiary, is also focused on high potency drugs, an immediate business synergy is expected. EirGen also offers the significant benefit of potentially being able to manufacture OPKO’s current and future products in our own facilities, which we expect will result in even higher gross margins. The superb management, research and development, manufacturing and product distribution teams, along with state of the art facilities, together, will create an important, tax efficient base of operations for OPKO,” said Dr. Frost.

Categories: M&A, Strategy


You Might Also Like
Read Full PostRead - Eye Icon
Key Legal Considerations When Drafting a Business Contract
Legal
01/05/2024Key Legal Considerations When Drafting a Business Contract

A well-written business contract is like an insurance policy, protecting you and your business in the event of something going wrong, and failing to have a written contract in place can be a costly mistake in the event of a contractual breach or a dispute.

Read Full PostRead - Eye Icon
A Look at Careers with Elevated Risks of Cancer and Occupational Diseases
News
23/08/2024A Look at Careers with Elevated Risks of Cancer and Occupational Diseases

Certain careers pose significant health risks due to inherent job-related hazards. Safety risks such as repeated stress injuries and dangerous chemicals are frequently encountered by workers in these industries. This exposure has the potential to cause major h

Read Full PostRead - Eye Icon
2 Easy Ways to Start Investing
Finance
16/04/20212 Easy Ways to Start Investing

Investing your money is the most reliable and effective way to create wealth over time and secure your future financial needs. This is why a lot of financial advisors would tell you to start while you’re young to witness solid returns. It’s placing your mo

Read Full PostRead - Eye Icon
Allen & Overy Advise During HIG European Capital Partners’ Acquisition of Centros Unico
M&A
20/08/2015Allen & Overy Advise During HIG European Capital Partners’ Acquisition of Centros Unico

Allen & Overy Advise During HIG European Capital Partners' Acquisition of Centros Unico

Read Full PostRead - Eye Icon
Emisys Acquisition of Minoriry Stake in Club Del Sole
M&A
31/07/2015Emisys Acquisition of Minoriry Stake in Club Del Sole

Emisys Acquisition of Minoriry Stake in Club Del Sole

Read Full PostRead - Eye Icon
How Can Digital Business Cards Affect The Business World?
Innovation
05/01/2023How Can Digital Business Cards Affect The Business World?

In the digital age, traditional business cards have taken a back seat to newer and more efficient methods of exchanging contact information. As businesses begin to explore digital options for their business cards, it's clear that these technological upgrades c

Read Full PostRead - Eye Icon
5 Essentials Of An Effective Equipment Budget
Finance
27/03/20235 Essentials Of An Effective Equipment Budget

Are you a business owner planning to invest in equipment for efficient service and product delivery to your clients? What plans do you have in place to actualize the dream?

Read Full PostRead - Eye Icon
Insurance for Insurance – Barents RE Have It Covered
Finance
27/01/2020Insurance for Insurance – Barents RE Have It Covered

Over the course of twenty-four years, Barents RE have cultivated a presence across Europe, the Middle East, Latin America and Asia as one of the world’s most established independent reinsurance groups. Now, with up to six hundred reinsurance connections acro

Read Full PostRead - Eye Icon
Colina Financial Advisors Ltd : Creating A Lasting Legacy
Finance
12/04/2019Colina Financial Advisors Ltd : Creating A Lasting Legacy

Colina Financial Advisors Ltd : Creating A Lasting Legacy Based in Nassau, The Bahamas, Colina Financial Advisors Ltd (CFAL) is a leading independent investment and advisory firm with a long and proven record of financial stability and integrity in all economi



Our Trusted Brands

Acquisition International is a flagship brand of AI Global Media. AI Global Media is a B2B enterprise and are committed to creating engaging content allowing businesses to market their services to a larger global audience. We have 14 unique brands, each of which serves a specific industry or region. Each brand covers the latest news in its sector and publishes a digital magazine and newsletter which is read by a global audience.

Arrow